DRD2, dopamine receptor D2, 1813

N. diseases: 437; N. variants: 42
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 GeneticVariation group BEFREE Abnormalities of the D<sub>2</sub>R gene (DRD2) play a role in the pathogenesis of human essential hypertension; variants of the DRD2 have been reported to be associated with hypertension. 29654295 2018
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 GeneticVariation group BEFREE Common single nucleotide polymorphisms (SNPs) rs6276, 6277, and 1800497 in the human D2R gene are associated with decreased receptor expression/function and hypertension. 25801876 2015
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 GeneticVariation group BEFREE Some common single-nucleotide polymorphisms (SNPs; rs6276, rs6277, and rs1800497) in the human DRD2 gene are associated with decreased D2R expression and function, as well as high blood pressure. 24379187 2014
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 GeneticVariation group BEFREE Our data in normoglycaemic Hong Kong Chinese supports that the DD2R gene TaqI polymorphism is a marker associated with the pathogenesis of obesity and hypertension. 15939106 2005
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 Biomarker group CTD_human Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. 11566895 2001
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 GeneticVariation group BEFREE We have previously reported an association of the A2 allele of the dopamine D2 receptor (DRD2) TaqI polymorphism with increased blood pressure in normoglycaemic Chinese subjects, but conversely possibly with decreased indices of obesity. 11894971 2001
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.360 Biomarker group BEFREE A deficient dopamine D(2) receptor (DA2) formation or action may contribute to hypertension via an increase of catecholamine release. 11494094 2001